Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis science

References

• American Public Health Association. (2014). Regulating commercially legalized marijuana as a public health priority.
   Google Scholar
• Anderson, P., De Bruijn, A., Angus, K., Gordon, R., & Hastings, G. (2009). Impact of alcohol advertising and media exposure on adolescent alcohol use: a systematic review of longitudinal studies. Alcohol and Alcoholism, 44, 229–243. doi:10.1093/alcalc/agn115
   PubMed Web of Science ®Google Scholar
• Azorlosa, J. L., Heishman, S. J., Stitzer, M. L., & Mahaffey, J. M. (1992). Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs. Journal of Pharmacology and Experimental Therapeutics, 261, 114–122.
   PubMed Web of Science ®Google Scholar
• Babor, T., Mendelson, J. H., Greenberg, I., & Kuehnle, J. (1978). Experimental analysis of the ‘happy hour’: effects of purchase price on alcohol consumption. Psychopharmacology, 58, 35–41. doi:10.1007/BF00426787
   PubMed Web of Science ®Google Scholar
• Berg, C. J., Henriksen, L., Cavazos-Rehg, P., Schauer, G. L., & Freisthler, B. (2017). The development and pilot testing of the marijuana retail surveillance tool (MRST): Assessing marketing and point-of-sale practices among recreational marijuana retailers. Health Education Research, 32(6), 465–472. doi:10.1093/her/cyx071.
   PubMed Web of Science ®Google Scholar
• Bero, L. (2003). Implications of the tobacco industry documents for public health and policy. Annual Review of Public Health, 24, 267–288. doi:10.1146/annurev.publhealth.24.100901.140813
   PubMed Web of Science ®Google Scholar
• Bifulco, M., & Pisanti, S. (2015). Medicinal use of cannabis in Europe: the fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use. EMBO Reports, e201439742. doi:10.15252/embr.201439742
   Google Scholar
• Bonn-Miller, M. O., Loflin, M. J., Thomas, B. F., Marcu, J. P., Hyke, T., & Vandrey, R. (2017). Labeling accuracy of cannabidiol extracts sold online. JAMA, 318, 1708–1709. doi:10.1001/jama.2017.11909
   PubMed Web of Science ®Google Scholar
• Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161, 1967–1977. doi:10.1176/appi.ajp.161.11.1967
   PubMed Web of Science ®Google Scholar
• Budney, A. J., Vandrey, R. G., Hughes, J. R., Moore, B. A., & Bahrenburg, B. (2007). Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug & Alcohol Dependence, 86, 22–29. doi:10.1016/j.drugalcdep.2006.04.014
   PubMed Web of Science ®Google Scholar
• Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., Chaudhri, N., & Sved, A. F. (2008). The role of nicotine in smoking: a dual-reinforcement model. In The motivational impact of nicotine and its role in tobacco use (pp. 91–109). New York, NY: Springer.
   Google Scholar
• Campbell, C. A., Hahn, R. A., Elder, R., Brewer, R., Chattopadhyay, S., Fielding, J., … Middleton, J. C. (2009). The effectiveness of limiting alcohol outlet density as a means of reducing excessive alcohol consumption and alcohol-related harms. American Journal of Preventive Medicine, 37, 556–569. doi:10.1016/j.amepre.2009.09.028
   PubMed Web of Science ®Google Scholar
• Carter, L. P., & Griffiths, R. R. (2009). Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence, 105, S14–S25. doi:10.1016/j.drugalcdep.2009.04.003
   PubMed Web of Science ®Google Scholar
• Carter, L. P., Stitzer, M. L., Henningfield, J. E., O'Connor, R. J., Cummings, K. M., & Hatsukami, D. K. (2009). Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiology and Prevention Biomarkers, 18, 3241–3262. doi:10.1158/1055-9965.EPI-09-0948
   PubMed Web of Science ®Google Scholar
• Casarett, D. (2018). The achilles heel of medical cannabis research—Inadequate blinding of placebo-controlled trials. JAMA Internal Medicine, 178, 9–10. doi:10.1001/jamainternmed.2017.5308
   PubMed Web of Science ®Google Scholar
• Casswell, S. (2012). Current status of alcohol marketing policy—an urgent challenge for global governance. Addiction, 107, 478–485. doi:10.1111/j.1360-0443.2011.03701.x
   PubMed Web of Science ®Google Scholar
• Casswell, S., & Maxwell, A. (2005). Regulation of alcohol marketing: a global view. Journal of Public Health Policy, 26, 343–358. doi:10.1057/palgrave.jphp.3200040
   PubMed Web of Science ®Google Scholar
• Caulkins, J. P. (2018). Advertising restrictions on cannabis products for nonmedical use: Necessary but not sufficient? American Journal of Public Health, 108, 1. doi:10.2105/AJPH.2017.304199
   PubMed Web of Science ®Google Scholar
• Ceccarini, J., Kuepper, R., Kemels, D., Os, J., Henquet, C., & Van Laere, K. (2015). [18F] MK‐9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addiction Biology, 20, 357–367. doi:10.1111/adb.12116
   PubMed Web of Science ®Google Scholar
• Chaloupka, F. J., Grossman, M., & Saffer, H. (2002). The effects of price on alcohol consumption and alcohol-related problems. Alcohol Research & Health, 26, 22–34.
   Web of Science ®Google Scholar
• Community Preventive Services Task Force. (2006). Preventing excessive alcohol consumption: enhanced enforcement of laws prohibiting sales to minors. Retrieved from http://www.thecommunityguide.org/alcohol/lawsprohibitingsales.html
   Google Scholar
• Cooper, Z. D., Bedi, G., Ramesh, D., Balter, R., Comer, S. D., & Haney, M. (2018). Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology. Advance online publication. doi:10.1038/s41386-018-0011-2
   Web of Science ®Google Scholar
• Crippa, J. A., Crippa, A., Hallak, J. E., Martín-Santos, R., & Zuardi, A. W. (2016). Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol. Frontiers in Pharmacology, 7, 359.
   PubMed Web of Science ®Google Scholar
• D'amico, E. J., Miles, J. N., & Tucker, J. S. (2015). Gateway to curiosity: Medical marijuana ads and intention and use during middle school. Psychology of Addictive Behaviors, 29, 613. doi:10.1037/adb0000094
   PubMed Web of Science ®Google Scholar
• Di Marzo, V., & Centonze, D. (2015). Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes. CNS Neuroscience & Therapeutics, 21, 215–221. doi:10.1111/cns.12358
   PubMed Web of Science ®Google Scholar
• Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain – United States, 2016. Morbidity and Mortality Weekly Report, 65, 1–49.
   PubMed Web of Science ®Google Scholar
• Elder, R. W., Lawrence, B., Ferguson, A., Naimi, T. S., Brewer, R. D., Chattopadhyay, S. K., … Fielding, J. E. (2010). The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms. American Journal of Preventive Medicine, 38, 217–229. doi:10.1016/j.amepre.2009.11.005
   PubMed Web of Science ®Google Scholar
• Elder, R. W., Lawrence, B. A., Janes, G., Brewer, R. D., Toomey, T. L., Hingson, R. W., … Fielding, J. (2007). Enhanced enforcement of laws prohibiting sale of alcohol to minors: Systematic review of effectiveness for reducing sales and underage drinking. Transportation Research Circular, 2007(E-C123), 181–188.
   Google Scholar
• ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biological Psychiatry, 79, 613–619. doi:10.1016/j.biopsych.2016.01.004
   PubMed Web of Science ®Google Scholar
• Evanoff, A. B., Quan, T., Dufault, C., Awad, M., & Bierut, L. J. (2017). Physicians-in-training are not prepared to prescribe medical marijuana. Drug and Alcohol Dependence, 180, 151–155. doi:10.1016/j.drugalcdep.2017.08.010
   PubMed Web of Science ®Google Scholar
• Fiala, S. C., Dilley, J. A., Firth, C. L., & Maher, J. E. (2018). Exposure to Marijuana Marketing After Legalization of Retail Sales: Oregonians’ Experiences, 2015–2016. American Journal of Public Health, 108, 120–127. doi:10.2105/AJPH.2017.304136
   PubMed Web of Science ®Google Scholar
• Finley, E. P., Garcia, A., Rosen, K., McGeary, D., Pugh, M. J., & Potter, J. S. (2017). Evaluating the impact of prescription drug monitoring program implementation: A scoping review. BMC Health Services Research, 17, 420. doi:10.1186/s12913-017-2354-5
   PubMed Web of Science ®Google Scholar
• Fischer, B., Rehm, J., & Tyndall, M. (2016). Effective Canadian policy to reduce harms from prescription opioids: Learning from past failures. Canadian Medical Association Journal, 188, 1240–1244. doi:10.1503/cmaj.160356
   PubMed Web of Science ®Google Scholar
• Ghosh, T. S., Vigil, D. I., Maffey, A., Tolliver, R., Van Dyke, M., Kattari, L., … Wolk, L. (2017). Lessons learned after three years of legalized, recreational marijuana: The Colorado experience. Preventive Medicine, 104, 4–6. doi:10.1016/j.ypmed.2017.02.021
   PubMed Web of Science ®Google Scholar
• Gorelick, D. A., Goodwin, R. S., Schwilke, E., Schwope, D. M., Darwin, W. D., Kelly, D. L., … Huestis, M. A. (2012). Tolerance to effects of high-dose oral Δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. Journal of Analytical Toxicology, 37, 11–16.
   PubMed Web of Science ®Google Scholar
• Government of Canada. (2017) Task force of cannabis legalization and regulation. Retrieved from https://www.canada.ca/en/services/health/marijuana-cannabis/task-force-cannabis-legalization-regulation.html?_ga=2.95474972.1459448888.1519230371-601243692.1519230371
   Google Scholar
• Hahn, R. A., Kuzara, J. L., Elder, R., Brewer, R., Chattopadhyay, S., Fielding, J., … Lawrence, B. (2010). Effectiveness of policies restricting hours of alcohol sales in preventing excessive alcohol consumption and related harms. American Journal of Preventive Medicine, 39, 590–604. doi:10.1016/j.amepre.2010.09.016
   PubMed Web of Science ®Google Scholar
• Hall, W., & Lynskey, M. (2016a). Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. The Lancet Psychiatry, 3, 900–906. doi:10.1016/S2215-0366(16)30071-2
   PubMed Web of Science ®Google Scholar
• Hall, W., & Lynskey, M. (2016b). Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction, 111, 1764–1773. doi:10.1111/add.13428
   PubMed Web of Science ®Google Scholar
• Haney, M., Cooper, Z. D., Bedi, G., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2013). Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology, 38, 1557. doi:10.1038/npp.2013.54
   PubMed Web of Science ®Google Scholar
• Haney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., … Walsh, S. L. (2016). Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis. Neuropsychopharmacology, 41, 1974 doi:10.1038/npp.2015.367
   PubMed Web of Science ®Google Scholar
• Haney, M., Ramesh, D., Glass, A., Pavlicova, M., Bedi, G., & Cooper, Z. D. (2015). Naltrexone maintenance decreases cannabis self-administration and subjective effects in daily cannabis smokers. Neuropsychopharmacology, 40, 2489. doi:10.1038/npp.2015.108
   PubMed Web of Science ®Google Scholar
• Hao, Z., & Cowan, B. (2017). The cross-border spillover effects of recreational marijuana legalization (No. w23426). National Bureau of Economic Research.
   Google Scholar
• Haug, N. A., Kieschnick, D., Sottile, J. E., Babson, K. A., Vandrey, R., & Bonn-Miller, M. O. (2016). Training and practices of cannabis dispensary staff. Cannabis and Cannabinoid Research, 1, 244–251. doi:10.1089/can.2016.0024
   PubMedGoogle Scholar
• Henningfield, J. E., & Keenan, R. M. (1993). Nicotine delivery kinetics and abuse liability. Journal of Consulting and Clinical Psychology, 61, 743. doi:10.1037/0022-006X.61.5.743
   PubMed Web of Science ®Google Scholar
• Hindocha, C., Freeman, T. P., Schafer, G., Gardener, C., Das, R. K., Morgan, C. J., & Curran, H. V. (2015). Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users.. European Neuropsychopharmacology, 25, 325–334. doi:10.1037/0022-006X.61.5.743
   PubMed Web of Science ®Google Scholar
• Huestis, M. A., Boyd, S. J., Heishman, S. J., Preston, K. L., Bonnet, D., Le Fur, G., & Gorelick, D. A. (2007). Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology, 194, 505–515. doi:10.1007/s00213-007-0861-5
   PubMed Web of Science ®Google Scholar
• Jernigan, D. (2010). The extent of global alcohol marketing and its impact on youth. Contemporary Drug Problems, 37, 57–89. doi:10.1177/009145091003700104
   Google Scholar
• Jernigan, D., Sparks, M., Yang, E., & Schwartz, R. (2013). Using public health and community partnerships to reduce density of alcohol outlets. Preventing Chronic Disease, 11, 120090.
   Google Scholar
• Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., … Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559–574. doi:10.1146/annurev-publhealth-031914-122957
   PubMed Web of Science ®Google Scholar
• Krauss, M. J., Sowles, S. J., Sehi, A., Spitznagel, E. L., Berg, C. J., Bierut, L. J., & Cavazos-Rehg, P. A. (2017). Marijuana advertising exposure among current marijuana users in the US. Drug & Alcohol Dependence, 174, 192–200. doi:10.1016/j.drugalcdep.2017.01.017
   PubMed Web of Science ®Google Scholar
• Larance, B., Degenhardt, L., Peacock, A., Gisev, N., Mattick, R., Colledge, S., & Campbell, G. (2018). Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses. Drug and Alcohol Review, 37, S203–S205. http:10.1111/dar.12617
   PubMed Web of Science ®Google Scholar
• Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J. F., Beslot, F., … Vassart, G. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401–404. doi:10.1126/science.283.5400.401
   PubMed Web of Science ®Google Scholar
• Miller, J. W., Naimi, T. S., Brewer, R. D., & Jones, S. E. (2007). Binge drinking and associated health risk behaviors among high school students. Pediatrics, 119, 76–85. doi:10.1542/peds.2006-1517
   PubMed Web of Science ®Google Scholar
• National Academics of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for future research. Washington, DC: The National Academies Press.
   Google Scholar
• Park, J. Y., & Wu, L. T. (2017). Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. Drug and Alcohol Dependence, 177, 1–13. doi:10.1016/j.drugalcdep.2017.03.009
   PubMed Web of Science ®Google Scholar
• Ramaekers, J. G., Kauert, G., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Moeller, M. R. (2006). High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology, 31, 2296.
   PubMed Web of Science ®Google Scholar
• Saffer, H., & Dave, D. (2006). Alcohol advertising and alcohol consumption by adolescents. Health Economics, 15, 617–637. doi:10.1002/hec.1091
   PubMed Web of Science ®Google Scholar
• Saltz, R. F. (1997). Evaluating specific community structural changes. Examples from the assessment of responsible beverage service. Evaluation Review, 21, 246–267. doi:10.1177/0193841X9702100207
   PubMed Web of Science ®Google Scholar
• Sawler, J., Stout, J. M., Gardner, K. M., Hudson, D., Vidmar, J., Butler, L., … Myles, S. (2015). The genetic structure of marijuana and hemp. PloS One, 10, e0133292 doi:10.1371/journal.pone.0133292
   PubMed Web of Science ®Google Scholar
• Sznitman, S. R., & Bretteville-Jensen, A. L. (2015). Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies. Harm Reduction Journal, 12, 46. doi:10.1186/s12954-015-0082-x
   PubMed Web of Science ®Google Scholar
• The President’s Commission on Combating Drug Addiction and the Opioid Crisis. Final Report. (2017). Tobacco.org. Retrieved from http://archive.tobacco.org/Resources/599ingredients.html
   Google Scholar
• Thomas, D. C. (2013). Invited commentary: is it time to retire the “pack-years” variable? Maybe not!. American Journal of Epidemiology, 179, 299–302.
   PubMed Web of Science ®Google Scholar
• United States Department of Health and Human Services, National Institute of Health, National Institute on Alcohol Abuse and Alcoholism. National Institute on Alcohol Abuse and Alcoholism Strategic Plan: 2017-2021. 2017.
   Google Scholar
• United States Food and Drug Administration (US FDA). (2012). Harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. Federal Register, 77, 20034–20037.
   Google Scholar
• Vandrey, R., Raber, J. C., Raber, M. E., Douglass, B., Miller, C., & Bonn-Miller, M. O. (2015). Cannabinoid dose and label accuracy in edible medical cannabis products. Jama, 313, 2491–2493. doi:10.1001/jama.2015.6613
   PubMed Web of Science ®Google Scholar
• Vansickel, A. R., Weaver, M. F., & Eissenberg, T. (2012). Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction, 107, 1493–1500. doi:10.1111/j.1360-0443.2012.03791.x
   PubMed Web of Science ®Google Scholar
• Walsh, S. L., & Babalonis, S. (2017). The abuse potential of prescription opioids in humans – closing in on the first century of research. Current Topics in Behavioral Neuroscience, 34, 33–58. https://doi.org/10.1007/7854_2016_448
   PubMedGoogle Scholar
• Walsh, S. L., Nuzzo, P. A., Lofwall, M. R., & Holtman, J. R. (2008). The relative abuse liability of oral oxycodone, hydrocodone, and hydromorphone assessed in prescription opioid abusers. Drug and Alcohol Dependence, 98, 191–202. doi:10.1016/j.drugalcdep.2008.05.007
   PubMed Web of Science ®Google Scholar
• Welch, S. P., & Eads, M. (1999). Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Research, 848, 183–190. doi:10.1016/S0006-8993(99)01908-3
   PubMed Web of Science ®Google Scholar
• White, A. G., LeCates, J., Birnbaum, H. G., Cheng, W., Roland, C. L., & Mardekian, J. (2015). Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs. Journal of Opioid Management, 11, 199–210. doi:10.5055/jom.2015.0269
   PubMedGoogle Scholar
• World Health Organization. (2012). Alcohol in the European Union: consumption, harm and policy approaches: Final report, Copenhagen 27 March 2012.
   Google Scholar